Before his career in pharmaceutical sales management, Terrell “Terry” Herring attended The Citadel, Military College of South Carolina in Charleston where he earned a bachelor of science degree in biology. Terrell “Terry” Herring also attended Duke University/London Fuqua School of Business where he earned a graduate certificate in international marketing.
A global business school connected with Duke University, the Fuqua School of Business in London, England offers a graduate program in international marketing. The international program caters to students with an interest in marketing and focuses on customer assets and developing good stewardship of firm brand equity. The marketing program includes training in product management along with market analysis and strategies. The program specifically focuses on courses such as market intelligence, consumer behavior, and forecasting. Students who earn a marketing certificate may qualify for careers in a variety of areas like health care, high-technology, and consumer goods and services.
0 Comments
President of commercial operations for Mission Pharmacal Company Terrell Herring is an established pharmaceutical marketing executive. In addition to his day job, Terrell “Terry” Herring serves as a board member for several organizations, including BioAgilytix. BioAgilytix provides large molecule global studies performed by researchers from around the world. The company has become a preferred bioanalytical laboratory for many companies in the biotech and pharma fields, offering services in areas such as pharmacokinetics. Pharmacokenetics helps determine how the human body reacts to various pharmaceuticals. This is essential to determining a drug’s safety and effectiveness. The pharmacokinetic assay procedures used by BioAgilytix comply with international regulations and regulatory standards, including FDA guidelines for industry regarding population pharmacokenetics. The population pharmacokenetics process helps identify the differences between - and effectiveness in - a drug’s effect on population subgroups. The FDA guidelines give researchers more information on when a population study should be performed as well as how to execute the study and what parameters to use. Due to constant changes and effectiveness in subgroups, constant communication is required between the FDA review staff and sponsors of a given study. |
AuthorTerrell Herring began working at Mission Pharmacal Company in 2010, bringing more than 25 years of experience in the pharmaceutical industry to his role as President of Commercial Operations. Archives
February 2018
Categories
All
|